PERSPECTA

News from every angle

Back to headlines

Scribe Therapeutics and JinkoSolar Release Second Quarter 2026 Financial Updates

Scribe Therapeutics published its Q2 2026 financial results alongside corporate highlights, while JinkoSolar released its quarterly earnings call transcript. Both companies disclosed their latest performance metrics to investors and analysts.

2 Sept, 20:05 — 2 Sept, 20:05
PostShare